\-\ Texto\\:\\ \ \(0\)\
\-\ mental\\ status\\ change\\ with\\ abnormal\\ laboratory\\ values\\.\ \(0\)\
\-\ treatment\\ of\\ osmotic\\ myelinolysis\\ is\\ to\\ centered\\ on\\ the\\ slow\\ correction\\ of\\ the\\ offending\\ hyponatremia\\.\ \(0\)\
\-\ t1wi\\ shows\\ a\\ low\\ signal\\ area\\ centered\\ in\\ the\\ pons\\ without\\ enhancement\\ on\\ post\\ gd\\ t1wi\\ sequence\\.\\ \\ t2wi\\ shows\\ increased\\ sigal\\ in\\ the\\ centered\\ in\\ the\\ pons\\.\\ \\ diffusion\\ weighted\\ sequence\\ also\\ shows\\ high\\ signal\\ in\\ the\\ pons\\.\ \(0\)\
\-\ central\\ pontine\\ myelinolysis\\ \\(cpm\\)\\ \\(osmotic\\ myelinolysis\\)\ \(0\)\
\-\ pontine\\ glioma\\,\\ ischemia\\/infarct\\,\\ multiple\\ sclerosis\\,\\ radiation\\ change\\,\\ osmotic\\ myelinolysis\ \(0\)\
\-\ 32\\ year\\ old\\ who\\ presented\\ to\\ the\\ emergency\\ department\\ with\\ a\\ history\\ of\\ alcohol\\ abuse\\.\\ \\ the\\ following\\ day\\ the\\ patient\\ was\\ noted\\ to\\ be\\ obtunded\\.\ \(0\)\
\-\ osmotic\\ myelinolysis\\ is\\ commonly\\ found\\ in\\ patients\\ with\\ a\\ concomitant\\ history\\ of\\ alcoholism\\,\\ malnourishment\\ or\\ chronically\\ debilitation\\.\\ \\ pathologically\\ it\\ is\\ characterized\\ by\\ myelin\\ loss\\ with\\ relative\\ neuronal\\ sparing\\.\\ \\ the\\ central\\ pons\\ is\\ the\\ most\\ common\\ site\\ of\\ involvement\\ \\(90\\%\\)\\ but\\ can\\ also\\ be\\ seen\\ affecting\\ the\\ basal\\ ganglia\\,\\ thalami\\,\\ and\\ sub\\-cortical\\ white\\ matter\\.\\ \\ if\\ a\\ nect\\ were\\ available\\ it\\ would\\ show\\ a\\ noon\\-specific\\ hypodense\\ region\\ to\\ normal\\ scan\\ of\\ the\\ affected\\ region\\.\\ \\ the\\ mri\\ changes\\ are\\ secondary\\ to\\ increased\\ water\\ content\\,\\ with\\ enhancement\\ patterns\\ varying\\.\\ \\ signal\\ abnormalities\\ involving\\ the\\ pons\\ can\\ have\\ a\\ wide\\ ranging\\ differential\\ including\\:\\ infarct\\,\\ glioma\\,\\ ms\\,\\ encephalitis\\,\\ and\\ radiation\\ changes\\.\\ \\ if\\ concomitant\\ abnormality\\ is\\ seen\\ in\\ the\\ basal\\ ganglia\\ then\\ the\\ differential\\ narrows\\ to\\ hypoxia\\,\\ wilson\\â\\€\\™s\\ disease\\ and\\ leigh\\â\\€\\™s\\ disease\\.\\ \\ a\\ combination\\ of\\ radiologic\\ findings\\ and\\ clinical\\ history\\ is\\ usually\\ helpful\\ in\\ narrowing\\ the\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myelinolysis\\:\\ 0\\.1387932758147192\ \(0\)\
\-\ osmotic\\:\\ 0\\.10368461167672516\ \(0\)\
\-\ pons\\:\\ 0\\.08783620128133403\ \(0\)\
\-\ centered\\:\\ 0\\.05405240216758467\ \(0\)\
\-\ pontine\\:\\ 0\\.04186896511088135\ \(0\)\
\-\ concomitant\\:\\ 0\\.03998145241687062\ \(0\)\
\-\ t1wi\\:\\ 0\\.037842952248036583\ \(0\)\
\-\ sequence\\:\\ 0\\.034857744679240125\ \(0\)\
\-\ sigal\\:\\ 0\\.031710497927937044\ \(0\)\
\-\ malnourishment\\:\\ 0\\.031710497927937044\ \(0\)\
\-\ debilitation\\:\\ 0\\.031710497927937044\ \(0\)\
\-\ noon\\-specific\\:\\ 0\\.031710497927937044\ \(0\)\
\-\ ganglia\\:\\ 0\\.0314594760250085\ \(0\)\
\-\ cpm\\:\\ 0\\.029217162746066738\ \(0\)\
\-\ ischemia\\/infarct\\:\\ 0\\.029217162746066738\ \(0\)\
\-\ sub\\-cortical\\:\\ 0\\.029217162746066738\ \(0\)\
\-\ basal\\:\\ 0\\.028025449626894773\ \(0\)\
\-\ glioma\\:\\ 0\\.027717077652565404\ \(0\)\
\-\ shows\\:\\ 0\\.025352953594196533\ \(0\)\
\-\ gd\\:\\ 0\\.025265319981073536\ \(0\)\
\-\ nect\\:\\ 0\\.025265319981073536\ \(0\)\
\-\ hyponatremia\\:\\ 0\\.024710821132774046\ \(0\)\
\-\ narrows\\:\\ 0\\.024710821132774046\ \(0\)\
\-\ signal\\:\\ 0\\.024313751765533586\ \(0\)\
\-\ change\\:\\ 0\\.023962025111337003\ \(0\)\
\-\ myelin\\:\\ 0\\.02380681239795064\ \(0\)\
\-\ leigh\\:\\ 0\\.02380681239795064\ \(0\)\
\-\ offending\\:\\ 0\\.02342781773731098\ \(0\)\
\-\ chronically\\:\\ 0\\.02342781773731098\ \(0\)\
\-\ alcoholism\\:\\ 0\\.021969310154188088\ \(0\)\
\-\ obtunded\\:\\ 0\\.021737157200455815\ \(0\)\
\-\ neuronal\\:\\ 0\\.021737157200455815\ \(0\)\
\-\ ranging\\:\\ 0\\.021118990808633303\ \(0\)\
\-\ content\\:\\ 0\\.020758978367780845\ \(0\)\
\-\ wilson\\:\\ 0\\.020591640182043822\ \(0\)\
\-\ pathologically\\:\\ 0\\.02043174175553003\ \(0\)\
\-\ central\\:\\ 0\\.020227563718416972\ \(0\)\
\-\ radiation\\:\\ 0\\.020174469421311774\ \(0\)\
\-\ patterns\\:\\ 0\\.019597922999928144\ \(0\)\
\-\ differential\\:\\ 0\\.019517696614049854\ \(0\)\
\-\ hypoxia\\:\\ 0\\.01947597497231778\ \(0\)\
\-\ thalami\\:\\ 0\\.019358025969357383\ \(0\)\
\-\ t2wi\\:\\ 0\\.018441147373570367\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.018374293090974502\ \(0\)\
\-\ sparing\\:\\ 0\\.01826564318591054\ \(0\)\
\-\ varying\\:\\ 0\\.018017467389194887\ \(0\)\
\-\ abuse\\:\\ 0\\.017861046123224606\ \(0\)\
\-\ s\\:\\ 0\\.01763142206557257\ \(0\)\
\-\ changes\\:\\ 0\\.017619050188741443\ \(0\)\
\-\ correction\\:\\ 0\\.017567240256266808\ \(0\)\
\-\ water\\:\\ 0\\.017428872339620063\ \(0\)\
\-\ region\\:\\ 0\\.017364037606038222\ \(0\)\
\-\ encephalitis\\:\\ 0\\.017167148043640102\ \(0\)\
\-\ affecting\\:\\ 0\\.01710458781805784\ \(0\)\
\-\ if\\:\\ 0\\.01668160743727076\ \(0\)\
\-\ slow\\:\\ 0\\.01663979741705062\ \(0\)\
\-\ wide\\:\\ 0\\.01647989899053683\ \(0\)\
\-\ enhancement\\:\\ 0\\.016478336446928317\ \(0\)\
\-\ ms\\:\\ 0\\.016428140942147982\ \(0\)\
\-\ hypodense\\:\\ 0\\.016377117075270443\ \(0\)\
\-\ radiologic\\:\\ 0\\.01599305960971035\ \(0\)\
\-\ helpful\\:\\ 0\\.015903126867964242\ \(0\)\
\-\ alcohol\\:\\ 0\\.015484384595142621\ \(0\)\
\-\ combination\\:\\ 0\\.015484384595142621\ \(0\)\
\-\ values\\:\\ 0\\.015367710941354298\ \(0\)\
\-\ 32\\:\\ 0\\.015329645799877546\ \(0\)\
\-\ characterized\\:\\ 0\\.015291979253592311\ \(0\)\
\-\ increased\\:\\ 0\\.015039458861868027\ \(0\)\
\-\ relative\\:\\ 0\\.014642396746774275\ \(0\)\
\-\ 90\\:\\ 0\\.014489304608577168\ \(0\)\
\-\ mental\\:\\ 0\\.014342462901669776\ \(0\)\
\-\ can\\:\\ 0\\.013944045701216328\ \(0\)\
\-\ it\\:\\ 0\\.01381905312613681\ \(0\)\
\-\ department\\:\\ 0\\.013783855403806338\ \(0\)\
\-\ diffusion\\:\\ 0\\.013759301572617849\ \(0\)\
\-\ infarct\\:\\ 0\\.013638985263022381\ \(0\)\
\-\ weighted\\:\\ 0\\.013365654662382374\ \(0\)\
\-\ affected\\:\\ 0\\.013300448242984689\ \(0\)\
\-\ site\\:\\ 0\\.012991049413272313\ \(0\)\
\-\ history\\:\\ 0\\.012736128104752699\ \(0\)\
\-\ \\,\\:\\ 0\\.012659103783182503\ \(0\)\
\-\ narrowing\\:\\ 0\\.012325347820683445\ \(0\)\
\-\ seen\\:\\ 0\\.01214840010840065\ \(0\)\
\-\ is\\:\\ 0\\.012135772195353792\ \(0\)\
\-\ also\\:\\ 0\\.012119565422087421\ \(0\)\
\-\ matter\\:\\ 0\\.012102445936693518\ \(0\)\
\-\ emergency\\:\\ 0\\.011639527330864301\ \(0\)\
\-\ commonly\\:\\ 0\\.011599033969264897\ \(0\)\
\-\ abnormality\\:\\ 0\\.01134013648859911\ \(0\)\
\-\ laboratory\\:\\ 0\\.011327668114582972\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011290520221936032\ \(0\)\
\-\ involvement\\:\\ 0\\.011265966390747542\ \(0\)\
\-\ including\\:\\ 0\\.011098628205010518\ \(0\)\
\-\ sclerosis\\:\\ 0\\.011040702278512032\ \(0\)\
\-\ status\\:\\ 0\\.010972400435905229\ \(0\)\
\-\ would\\:\\ 0\\.010938729778496727\ \(0\)\
\-\ then\\:\\ 0\\.010938729778496727\ \(0\)\
\-\ involving\\:\\ 0\\.010785637640299618\ \(0\)\
\-\ in\\:\\ 0\\.010610721622236636\ \(0\)\
\-\ available\\:\\ 0\\.010333521758416536\ \(0\)\
\-\ white\\:\\ 0\\.010194619470187115\ \(0\)\
\-\ disease\\:\\ 0\\.01004847151953744\ \(0\)\
\-\ a\\:\\ 0\\.009986325945072694\ \(0\)\
\-\ day\\:\\ 0\\.009758848307024927\ \(0\)\
\-\ area\\:\\ 0\\.009718835410554919\ \(0\)\
\-\ found\\:\\ 0\\.009687142498029181\ \(0\)\
\-\ post\\:\\ 0\\.009679262708893143\ \(0\)\
\-\ be\\:\\ 0\\.009480264196718916\ \(0\)\
\-\ clinical\\:\\ 0\\.009457948921100735\ \(0\)\
\-\ show\\:\\ 0\\.009435812713998655\ \(0\)\
\-\ usually\\:\\ 0\\.009334274294484746\ \(0\)\
\-\ to\\:\\ 0\\.009217297304524884\ \(0\)\
\-\ the\\:\\ 0\\.008951392534767138\ \(0\)\
\-\ loss\\:\\ 0\\.00892253299449079\ \(0\)\
\-\ abnormal\\:\\ 0\\.008766518850053638\ \(0\)\
\-\ following\\:\\ 0\\.008724020708277512\ \(0\)\
\-\ scan\\:\\ 0\\.00860529302314021\ \(0\)\
\-\ secondary\\:\\ 0\\.008593632973053265\ \(0\)\
\-\ low\\:\\ 0\\.008547367096641726\ \(0\)\
\-\ high\\:\\ 0\\.008412036190923797\ \(0\)\
\-\ presented\\:\\ 0\\.00837898429864176\ \(0\)\
\-\ common\\:\\ 0\\.008044126661713658\ \(0\)\
\-\ who\\:\\ 0\\.008014274853027706\ \(0\)\
\-\ patients\\:\\ 0\\.007955304314266281\ \(0\)\
\-\ \\(\\:\\ 0\\.007795270427092021\ \(0\)\
\-\ \\)\\:\\ 0\\.00770004703719394\ \(0\)\
\-\ noted\\:\\ 0\\.007285687728246741\ \(0\)\
\-\ without\\:\\ 0\\.007237457432943023\ \(0\)\
\-\ \\%\\:\\ 0\\.0071702195444101\ \(0\)\
\-\ most\\:\\ 0\\.007096529286791641\ \(0\)\
\-\ mri\\:\\ 0\\.00706214336300223\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007058342916476331\ \(0\)\
\-\ were\\:\\ 0\\.006979447254280293\ \(0\)\
\-\ have\\:\\ 0\\.006656252080449971\ \(0\)\
\-\ but\\:\\ 0\\.006555767269904812\ \(0\)\
\-\ findings\\:\\ 0\\.006542578905719279\ \(0\)\
\-\ multiple\\:\\ 0\\.00647412231467363\ \(0\)\
\-\ treatment\\:\\ 0\\.006221643739571537\ \(0\)\
\-\ on\\:\\ 0\\.0052078490098232235\ \(0\)\
\-\ by\\:\\ 0\\.005118240659154226\ \(0\)\
\-\ normal\\:\\ 0\\.0048187498366874144\ \(0\)\
\-\ are\\:\\ 0\\.004190193786077705\ \(0\)\
\-\ \\:\\:\\ 0\\.0040657367481678605\ \(0\)\
\-\ or\\:\\ 0\\.0036025998164162143\ \(0\)\
\-\ was\\:\\ 0\\.0035549551158765716\ \(0\)\
\-\ year\\:\\ 0\\.003439227587312643\ \(0\)\
\-\ old\\:\\ 0\\.0031472467513030743\ \(0\)\
\-\ patient\\:\\ 0\\.003081265938548158\ \(0\)\
\-\ of\\:\\ 0\\.002933548940956543\ \(0\)\
\-\ and\\:\\ 0\\.002590057636434798\ \(0\)\
\-\ with\\:\\ 0\\.0021043916562929806\ \(0\)\
\-\ \\.\\:\\ 0\\.0019154425951805544\ \(0\)\
